Wegovy Pill vs Injection: Which Works Better for Weight Loss?
- Injection: Once weekly, 2.4mg dose, ~100% bioavailability, no food restrictions
- Pill: Once daily, 50mg dose, ~1% bioavailability, must take on empty stomach
- Weight loss: Both show ~15-17% body weight loss in trials
- Real-world edge: Injection tends to perform better due to easier compliance
- Cost: Pill slightly cheaper (~$1,000-$1,500 vs $1,300-$1,700/month)
Key differences at a glance
| Factor | Wegovy Injection | Oral Wegovy (Pill) |
|---|---|---|
| Dosing | Once weekly | Once daily |
| Max dose | 2.4mg/week | 50mg/day |
| Bioavailability | ~100% | ~1% |
| Dosing restrictions | None | Empty stomach, 30 min wait |
| Weight loss (trials) | 15-17% body weight | 15-17% body weight |
| FDA approval | 2021 | 2024 (weight loss dose) |
| Cost | ~$1,300-$1,700/mo | ~$1,000-$1,500/mo |
How the Wegovy injection works
New to Wegovy? Start with our guide on what Wegovy is and how it works.
Wegovy injection delivers semaglutide directly under your skin using a pre-filled pen. You inject once per week, on the same day each week.
The process:
- Choose an injection site (abdomen, thigh, or upper arm)
- Clean the area with an alcohol swab
- Press the pen against your skin and click the button
- Hold for 5-10 seconds while the medication delivers
- Dispose of the pen safely
Most people say the injection is painless or feels like a small pinch. The needle is thin (similar to insulin pens), and the auto-injector does the work.
Injection dosing schedule
| Weeks | Dose |
|---|---|
| 1-4 | 0.25mg weekly |
| 5-8 | 0.5mg weekly |
| 9-12 | 1.0mg weekly |
| 13-16 | 1.7mg weekly |
| 17+ | 2.4mg weekly (maintenance) |
This slow ramp-up helps minimize nausea and other GI side effects.
How oral Wegovy works
Oral semaglutide comes as a tablet you swallow once daily. The pill version requires specific conditions to absorb properly.
- Take on an empty stomach, first thing in the morning
- Swallow with no more than 4 oz (120ml) of plain water
- Wait at least 30 minutes before eating, drinking, or taking other meds
- Do not crush, chew, or split the tablet
These rules exist because oral semaglutide has extremely low bioavailability (~1%). The tablet contains absorption enhancers that only work under specific conditions. Food, coffee, or too much water interfere with absorption.
Oral dosing schedule
| Month | Dose |
|---|---|
| 1 | 3mg daily |
| 2 | 7mg daily |
| 3 | 14mg daily |
| 4+ | 25mg or 50mg daily (weight loss dose) |
Effectiveness comparison
Both forms of semaglutide produce substantial weight loss (15%+ of body weight in trials), but the data is stronger for the injection.
Injectable Wegovy (STEP trials)
- Average weight loss: 15-17% of body weight over 68 weeks
- Losing ≥10%: About 70% of participants
- Losing ≥20%: About 30-35% of participants
Oral Semaglutide 50mg (OASIS 1 trial)
- Average weight loss: 15.1% of body weight over 68 weeks
- Losing ≥10%: About 69% of participants
- Losing ≥20%: About 34% of participants
The real-world difference
Clinical trials enforce perfect adherence. In real life:
- Injection compliance is typically higher (once weekly, no restrictions)
- Oral compliance suffers when people forget the fasting rules
- Missing doses or taking with food can cut absorption by 50% or more
Side effects comparison
Both delivery methods cause similar side effects because they use the same medication. See our full guide to semaglutide side effects for more details.
Common side effects (both forms)
- Nausea (most common)
- Vomiting
- Diarrhea
- Constipation
- Stomach pain
- Fatigue
- Headache
Injection-specific
- Injection site reactions: Mild redness or irritation (usually temporary)
- Side effect timing: Symptoms tend to spike 1-2 days after injection, then fade
Oral-specific
- Daily GI exposure: Some experience more constant low-level nausea
- Esophageal concerns: Rare irritation; always take with water and stay upright
In trials, discontinuation rates due to side effects were similar between forms (6-8%).
Cost comparison
| Injection | Oral | |
|---|---|---|
| List price | ~$1,300-$1,700/mo | ~$1,000-$1,500/mo |
| With insurance | $0-$500/mo (varies) | $0-$500/mo (varies) |
| Savings programs | Novo Nordisk card | Novo Nordisk card |
| Compounded versions | Available | Not available |
Important: Compounded semaglutide (from compounding pharmacies) is only available as an injection. If you’re considering compounded versions for cost savings, the pill isn’t an option.
For telehealth provider pricing, see our GLP-1 provider reviews.
Which one should you choose?
Choose the injection if:
- You’re comfortable with self-injection
- You want once-weekly dosing
- Your mornings are unpredictable
- You travel frequently
- You want compounded semaglutide as an option
- You prefer the most-studied method
Choose the oral pill if:
- You have genuine needle phobia
- You can reliably take a pill and wait 30 min daily
- You have a consistent morning routine
- You don’t drink coffee first thing
- You prefer swallowing a pill to injecting
The needle question
Most people who think they “can’t do needles” find that Wegovy’s auto-injector is manageable. The needle is small, the injection is quick, and you don’t see the needle during use. If needle fear is your only reason for choosing the pill, consider trying the injection first—it may be easier than you expect.
Our recommendation
For most people, we recommend starting with the injectable Wegovy. The weekly dosing is actually more convenient than daily pills with 30-minute fasting requirements, and the efficacy data has more long-term follow-up.
The oral version is a good alternative for people who genuinely cannot self-inject, but it requires more discipline around daily timing and food restrictions.
Frequently asked questions
The bottom line
Both Wegovy injection and oral semaglutide can help you lose 15%+ of your body weight. The injection offers easier compliance and stronger clinical evidence. The pill offers needle-free convenience but demands strict daily adherence.
For most people, the weekly injection is the better choice. If you have true needle phobia, the oral version is a viable alternative—just be prepared to follow the dosing rules exactly.
References
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384(11):989-1002. doi:10.1056/NEJMoa2032183
- Knop FK, et al. Oral semaglutide 50 mg taken once daily in adults with overweight or obesity (OASIS 1). Lancet. 2023;402(10403):705-719. doi:10.1016/S0140-6736(23)01185-6
- FDA approves first oral GLP-1 treatment for type 2 diabetes. FDA News Release. September 2019.
- Novo Nordisk. Wegovy (semaglutide) injection prescribing information. 2021.
- Aroda VR, et al. PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy. Diabetes Care. 2019;42(9):1724-1732.